Cambridge Trust’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-274
| Closed | -$15.7K | – | 724 |
|
|
2023
Q1 | $15.7K | Sell |
274
-1,025
| -79% | -$58.8K | ﹤0.01% | 583 |
|
|
2022
Q4 | $73K | Hold |
1,299
| – | – | ﹤0.01% | 411 |
|
|
2022
Q3 | $55K | Sell |
1,299
-1,858
| -59% | -$78.7K | ﹤0.01% | 440 |
|
|
2022
Q2 | $171K | Sell |
3,157
-319
| -9% | -$17.3K | 0.01% | 317 |
|
|
2022
Q1 | $223K | Sell |
3,476
-2
| -0.1% | -$128 | 0.01% | 321 |
|
|
2021
Q4 | $233K | Buy |
3,478
+54
| +2% | +$3.62K | 0.01% | 316 |
|
|
2021
Q3 | $234K | Sell |
3,424
-417
| -11% | -$28.5K | 0.01% | 253 |
|
|
2021
Q2 | $262K | Sell |
3,841
-1,023
| -21% | -$69.8K | 0.01% | 241 |
|
|
2021
Q1 | $336K | Sell |
4,864
-623
| -11% | -$43K | 0.01% | 208 |
|
|
2020
Q4 | $356K | Sell |
5,487
-2,337
| -30% | -$152K | 0.02% | 177 |
|
|
2020
Q3 | $370K | Sell |
7,824
-8,175
| -51% | -$387K | 0.02% | 176 |
|
|
2020
Q2 | $759K | Sell |
15,999
-638
| -4% | -$30.3K | 0.04% | 132 |
|
|
2020
Q1 | $743K | Sell |
16,637
-1,567
| -9% | -$70K | 0.05% | 138 |
|
|
2019
Q4 | $1.06M | Sell |
18,204
-909
| -5% | -$52.9K | 0.06% | 139 |
|
|
2019
Q3 | $1.15M | Buy |
19,113
+33
| +0.2% | +$1.98K | 0.07% | 126 |
|
|
2019
Q2 | $1.07M | Sell |
19,080
-509
| -3% | -$28.4K | 0.06% | 130 |
|
|
2019
Q1 | $1.09M | Sell |
19,589
-422
| -2% | -$23.5K | 0.07% | 129 |
|
|
2018
Q4 | $903K | Sell |
20,011
-272
| -1% | -$12.3K | 0.06% | 131 |
|
|
2018
Q3 | $1.34M | Sell |
20,283
-534
| -3% | -$35.2K | 0.08% | 119 |
|
|
2018
Q2 | $1.34M | Buy |
20,817
+719
| +4% | +$46.3K | 0.08% | 111 |
|
|
2018
Q1 | $1.11M | Buy |
20,098
+429
| +2% | +$23.7K | 0.07% | 128 |
|
|
2017
Q4 | $941K | Sell |
19,669
-7,267
| -27% | -$348K | 0.06% | 135 |
|
|
2017
Q3 | $1.36M | Buy |
26,936
+348
| +1% | +$17.6K | 0.09% | 110 |
|
|
2017
Q2 | $1.45M | Buy |
26,588
+1,404
| +6% | +$76.5K | 0.1% | 108 |
|
|
2017
Q1 | $1.06M | Buy |
25,184
+6,250
| +33% | +$263K | 0.07% | 129 |
|
|
2016
Q4 | $812K | Buy |
18,934
+790
| +4% | +$33.9K | 0.06% | 142 |
|
|
2016
Q3 | $749K | Buy |
18,144
+1,544
| +9% | +$63.7K | 0.05% | 142 |
|
|
2016
Q2 | $662K | Buy |
16,600
+990
| +6% | +$39.5K | 0.05% | 146 |
|
|
2016
Q1 | $526K | Buy |
15,610
+3,326
| +27% | +$112K | 0.04% | 147 |
|
|
2015
Q4 | $416K | Buy |
12,284
+522
| +4% | +$17.7K | 0.03% | 155 |
|
|
2015
Q3 | $350K | Buy |
+11,762
| New | +$350K | 0.03% | 166 |
|